<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39318618</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Nasopharyngeal carriage of <i>Streptococcus pneumoniae</i> among children aged 30 days to &lt;60 months in Beijing and Shenzhen, China (2018-2021) during pneumococcal conjugate vaccine introduction and the coronavirus disease (COVID-19) pandemic.</ArticleTitle><Pagination><StartPage>1382165</StartPage><MedlinePgn>1382165</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1382165</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2024.1382165</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To describe the carriage rate, serotype distribution, and antimicrobial susceptibility patterns of <i>Streptococcus pneumoniae</i> (<i>S. pneumoniae</i>) nasopharyngeal (NP) isolates among healthy children aged 30 days to &lt;60 months in the cities of Beijing and Shenzhen during 2018-2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A NP swab sample was collected among four annual cohorts of healthy children at routine well-child visits. <i>S. pneumoniae</i> was identified by culture, optochin sensitivity and bile solubility, serotypes determined by latex agglutination and Quellung, and antimicrobial susceptibility testing performed using E-test strips.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED"><i>S. pneumoniae</i> NP carriage was 13.1% (645/4,911), with the highest <i>S. pneumoniae</i> carriage prevalence (15.3%) observed in 25 to &lt;60 months. The carriage prevalence was 15.1% in children 13-24 months, 13.2% in children 7-12 months, and 8.2% in children 30 days to 6 months (<i>P</i> &lt; 0.01). Living with siblings [20.0% vs. 9.4%: OR: 2.42 (95% CI: 2.05-2.87)] or attending day-care [31.8% vs. 11.3%: OR: 3.67 (95% CI: 2.94-4.57)] increased the risk (<i>P</i> &lt; 0.01). During the period (January 2020-April 2021) of strict non-pharmaceutical interventions to prevent and control the COVID-19 pandemic, the proportion of children with <i>S. pneumoniae</i> colonization declined from 16.0% (94/587) to 5.8% (108/1,848) in Beijing while increasing from 14.5% (64/443) to 18.6% (379/2,033) in Shenzhen. Among <i>S. pneumoniae</i> isolates, 36.7% (237/645) belonged to 13-valent pneumococcal conjugate vaccine (PCV13) serotypes, 64.3% (408/645) were non-PCV13 serotypes, including 20.8% (134/645) non-serotypeable <i>S. pneumoniae</i> (NST). A total of 158/644 isolates (24.5%) were MDR. For the PCV13 isolates, MDR was detected in 36.3% (86/237) of isolates; in comparison, 17.6% (72/407) of non-PCV13 serotypes, including NST, were MDR (<i>P</i> &lt; 0.01). <i>S. pneumoniae</i> NP carriage was detected in 10.7% of children with previous pneumococcal vaccination (PCV7 or PCV13 only) compared with 14.9% in children without previous pneumococcal vaccination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The highest <i>S. pneumoniae</i> carriage prevalence were found in the oldest age group (25 to &lt;60 months) and in children living with siblings or attending day-care. Vaccination with PCV7 or PCV13 was associated with lower PCV13-serotype colonization. In Beijing, <i>S. pneumoniae</i> carriage significantly declined during the COVID-19 pandemic.</AbstractText><CopyrightInformation>© 2024 Du, Liu, Wang, Wang, Liu, Wen, Yu, Ren, Gonzalez, Arguedas, Fletcher, Pan, Morales, Deng and Yao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Du</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Zhaoqiu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Preventive Health, First Affiliated Hospital of Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongmei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yani</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shenzhen Nanshan Medical Group Headquarters, Taohua Yuan Community Health Service Center, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Preventive Health, Beijing Children's Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Xuexia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shenzhen Nanshan Medical Group Headquarters, Chiwan Community Health Service Center, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Sangjie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Qingqing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Shenzhen Nanshan Medical Group Headquarters, Haiwan Community Health Service Center, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vaccines/Antivirals &amp; Evidence Generation, Pfizer, Inc., Collegeville, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arguedas</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vaccines/Antivirals &amp; Evidence Generation, Pfizer, Inc., Collegeville, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Vaccines &amp; Antivirals, Emerging Markets, Pfizer, Inc., Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Kaijie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vaccines/Antivirals &amp; Evidence Generation, Pfizer, Inc., Collegeville, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Graciela Del Carmen</ForeName><Initials>GDC</Initials><AffiliationInfo><Affiliation>Vaccines, Medical Affairs, Emerging Markets, Pfizer, Inc., New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jikui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Kaihu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword><Keyword MajorTopicYN="N">antimicrobial resistance</Keyword><Keyword MajorTopicYN="N">nasopharyngeal carriage</Keyword><Keyword MajorTopicYN="N">pneumococcal conjugate vaccine</Keyword><Keyword MajorTopicYN="N">serotypes</Keyword></KeywordList><CoiStatement>EG, AA, MF, and KP are employees of Pfizer and may hold stock or stock options. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39318618</ArticleId><ArticleId IdType="pmc">PMC11421034</ArticleId><ArticleId IdType="doi">10.3389/fped.2024.1382165</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Francois Watkins LK, Milucky JL, McGee L, Siné St-Surin F, Liu P, Tran T, et al. Nasopharyngeal carriage of Streptococcus pneumoniae among young children in Haiti before pneumococcal conjugate vaccine Introduction. J Infect Dis. (2021) 224(12 Suppl 2):S248–57. 10.1093/infdis/jiab119</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab119</ArticleId><ArticleId IdType="pmc">PMC8414909</ArticleId><ArticleId IdType="pubmed">34469560</ArticleId></ArticleIdList></Reference><Reference><Citation>Daningrat WOD, Amalia H, Ayu IM, Satzke C, Safari D. Carriage of Streptococcus pneumoniae in children under five years of age prior to pneumococcal vaccine introduction in Southeast Asia: a systematic review and meta-analysis (2001–2019). J Microbiol Immunol Infect. (2022) 55(1):6–17. 10.1016/j.jmii.2021.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2021.08.002</ArticleId><ArticleId IdType="pubmed">34511388</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J, Nguyen CD, Dunne EM, Kim Mulholland E, Mungun T, Pomat WS, et al. Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries. Vaccine. (2019) 37(43):6299–309. 10.1016/j.vaccine.2019.08.073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.08.073</ArticleId><ArticleId IdType="pubmed">31500968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu S, Hu HL, Yang YH, Yao KH. A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed. Expert Rev Vaccines. (2017) 16(10):997–1006. 10.1080/14760584.2017.1360771</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2017.1360771</ArticleId><ArticleId IdType="pubmed">28745918</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenyan Y, Wei N, Zhu X, Wang QH, An ZJ. Investigation and analysis of pneumococcal vaccination in children in China. Zhong Guo Gong Gong Wei Sheng Za Zhi. (2018) 34(11):1468–70.</Citation></Reference><Reference><Citation>13-Valent Pneumococcal Conjugate Vaccine Label Information. Prevenar 13. USA: Pfizer Inc. (2016). Available online at:
pfizer.com
(Accessed December 28, 2023).</Citation></Reference><Reference><Citation>13-Valent Pneumococcal Conjugate Vaccine Label Information. Prevenar 13. USA: Pfizer Inc. (2023). Available online at:
pfizer.com
(Accessed December 28, 2023).</Citation></Reference><Reference><Citation>Wang J, Wu Q-S, Lu J, Ni Y-H, Zhou F. Low vaccination coverage of pneumococcal conjugate vaccines (PCVs) in Shanghai, China: a database analysis based on birth cohorts from 2012 to 2020. Vaccine. (2021) 39(42):6189–94. 10.1016/j.vaccine.2021.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.09.011</ArticleId><ArticleId IdType="pubmed">34538698</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics. Available at Beijing Statistical Yearbook-2016. Beijing: Beijing Municipal Bureau of Statistics;  (2016). Available online at: https://nj.tjj.beijing.gov.cn/nj/main/2016-tjnj/zk/e/indexeh.htm (Accessed December 28, 2023).</Citation></Reference><Reference><Citation>Fu W, Chen ZC, Wang GB, Fu DP, Feng XL. Analysis of vaccine coverage situation of children aged from 0 to 6 in Zhongguancun area in Beijing from 2011 to 2016. Zhong Guo Wei Sheng Chan Ye Za Zhi. (2017) 14(16):3–10. 10.16659/j.cnki.1672-5654.2017.16.003</Citation><ArticleIdList><ArticleId IdType="doi">10.16659/j.cnki.1672-5654.2017.16.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang WP. The category II vaccines: uses and current status among 0–3 years old children in Puhuangyu, Beijing. Shou Du Gong Gong Wei Sheng Za Zhi. (2017) 11(3):130–3. 10.16760/j.cnki.sdggws.2017.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.16760/j.cnki.sdggws.2017.03.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics. Shenzhen Statistical Yearbook. Shenzhen: Shenzhen Statistical Yearbook;  (2016). Available online at:
http://www.sz.gov.cn/cn/xxgk/zfxxgj/tjsj/tjnj/content/post_1347277.html (accessed December 15, 2018).</Citation></Reference><Reference><Citation>Fang Q, Wang YG, Cai L. A cross sectional survey of the vaccination rate of NIP vaccine and non-NIP vaccine among local children and migrant children in Futian, Shenzhen in 2013. Pract Prev Med. (2015) 22(3):322–3.</Citation></Reference><Reference><Citation>Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the world health organization pneumococcal carriage working group. Vaccine. (2013) 32(1):165–79. 10.1016/j.vaccine.2013.08.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.08.062</ArticleId><ArticleId IdType="pubmed">24331112</ArticleId></ArticleIdList></Reference><Reference><Citation>da Gloria Carvalho M, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, Millar EV, et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol. (2010) 48(5):1611–8. 10.1128/JCM.02243-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02243-09</ArticleId><ArticleId IdType="pmc">PMC2863911</ArticleId><ArticleId IdType="pubmed">20220175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sørensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol. (1993) 31(8):2097–100. 10.1128/jcm.31.8.2097-2100.1993</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.31.8.2097-2100.1993</ArticleId><ArticleId IdType="pmc">PMC265703</ArticleId><ArticleId IdType="pubmed">8370735</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: 29th edition of Performance Standards for Antimicrobial Susceptibility Testing published by CLSI. Clinical and Laboratory Standards Institute. (2019). M100. Available online at:
m100ed29_sample.pdf clsi.org
(Accessed December 15, 2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601225</ArticleId><ArticleId IdType="pubmed">34550809</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae–United States, 2006–2007. MMWR Morb Mortal Wkly Rep. (2008) 57(50):1353–5. Available online at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5750a2.htm (Accessed February 6, 2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">19092758</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet D. Modelling Binary Data. London: Chapman &amp; Hall; (1991). 369. 10.1007/978-1-4899-4475-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4899-4475-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresti A, Coull BA. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat. (1998) 52:119–26. 10.1080/00031305.1998.10480550</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00031305.1998.10480550</ArticleId></ArticleIdList></Reference><Reference><Citation>Janapatla RP, Su LH, Chen HH, Chang HJ, Tsai TC, Chen PY, et al. Epidemiology of culture-confirmed infections of Streptococcus pneumoniae (2012–2015) and nasopharyngeal carriage in children and households in Taiwan (2014–2015). J Med Microbiol. (2017) 66(6):729–36. 10.1099/jmm.0.000488</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.000488</ArticleId><ArticleId IdType="pubmed">28590240</ArticleId></ArticleIdList></Reference><Reference><Citation>Narwortey DK, Owusu-Ofori A, Slotved H-C, Donkor ES, Ansah PO, Welaga P, et al. Nasopharyngeal carriage of Streptococcus pneumoniae among healthy children in Kassena-Nankana districts of northern Ghana. BMC Infect Dis. (2021) 21:1–10. 10.1186/s12879-021-06302-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06302-5</ArticleId><ArticleId IdType="pmc">PMC8265090</ArticleId><ArticleId IdType="pubmed">34233627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada FW, Tufa EG, Berheto TM, Solomon FB. Nasopharyngeal carriage of Streptococcus pneumoniae and antimicrobial susceptibility pattern among school children in south Ethiopia: post-vaccination era. BMC Res Notes. (2019) 12(1):306. 10.1186/s13104-019-4330-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-019-4330-0</ArticleId><ArticleId IdType="pmc">PMC6542063</ArticleId><ArticleId IdType="pubmed">31142367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceyhan M, Karadag-Oncel E, Hascelik G, Ustundag G, Gurbuz V, Samlioglu P, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged less than five years. Vaccine. (2021) 39(15):2041–7. 10.1016/j.vaccine.2021.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.03.028</ArticleId><ArticleId IdType="pubmed">33741188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Fu J, Liang Z, Chen J. Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in China: a meta-analysis. BMC Infect Dis. (2017) 17(1):765. 10.1186/s12879-017-2816-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2816-8</ArticleId><ArticleId IdType="pmc">PMC5729489</ArticleId><ArticleId IdType="pubmed">29237402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjipanayis A, Efstathiou E, Alexandrou M, Panayiotou L, Zachariadou C, Petrou P, et al. Nasopharyngeal pneumococcal carriage among healthy children in Cyprus post widespread simultaneous implementation of PCV10 and PCV13 vaccines. PLoS One. (2016) 11(10):e0163269. 10.1371/journal.pone.0163269</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0163269</ArticleId><ArticleId IdType="pmc">PMC5051711</ArticleId><ArticleId IdType="pubmed">27706247</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhang Z, Zhang X, Xu C, Song Y, Li L, et al. Coverage of 13-valent pneumococcal conjugate vaccine among children 0–15 months of age—9 provinces, China, 2019–2021. China CDC Wkly. (2023) 5(17):379–84. 10.46234/ccdcw2023.072</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2023.072</ArticleId><ArticleId IdType="pmc">PMC10184383</ArticleId><ArticleId IdType="pubmed">37197448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rybak A, Levy C, Angoulvant F, Auvrignon A, Gembara P, Danis K, et al. Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France. JAMA Netw Open. (2022) 5(6):e2218959. 10.1001/jamanetworkopen.2022.18959</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.18959</ArticleId><ArticleId IdType="pmc">PMC9240903</ArticleId><ArticleId IdType="pubmed">35763298</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrović V, Milosavljević B, Djilas M, Marković M, Vuković V, Andrijević I, et al. Pneumococcal nasopharyngeal carriage in children under 5 years of age at an outpatient healthcare facility in Novi Sad, Serbia during the COVID-19 pandemic. IJID Reg. (2022) 4:88–96. 10.1016/j.ijregi.2022.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2022.07.001</ArticleId><ArticleId IdType="pmc">PMC9294645</ArticleId><ArticleId IdType="pubmed">35865274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussen S, Asnake S, Wachamo D, Tadesse BT. Pneumococcal nasopharyngeal carriage and antimicrobial susceptibility profile in children under five in southern Ethiopia. F1000Res. (2020) 9:1466. 10.12688/f1000research.27583.3</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27583.3</ArticleId><ArticleId IdType="pmc">PMC8278251</ArticleId><ArticleId IdType="pubmed">34316364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv M, Bai S, Sun Y, Zhang T, Li A, Wu J. Impact of the pneumococcal heptavalent conjugated vaccine on Streptococcus pneumoniae nasopharyngeal carriage and antimicrobial susceptibility in children 2–5 year old in Beijing, China. World J Vaccines. (2017) 7(03):27. 10.4236/wjv.2017.73003</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/wjv.2017.73003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. (1996) 174(6):1271–8. 10.1093/infdis/174.6.1271</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/174.6.1271</ArticleId><ArticleId IdType="pubmed">8940218</ArticleId></ArticleIdList></Reference><Reference><Citation>Syrogiannopoulos GA, Grivea IN, Moriondo M, Nieddu F, Michoula AN, Calabrese MR, et al. Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3+1 schedule. Sci Rep. (2021) 11(1):24534. 10.1038/s41598-021-03720-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03720-y</ArticleId><ArticleId IdType="pmc">PMC8718523</ArticleId><ArticleId IdType="pubmed">34969968</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller LE, Robinson DA, McDaniel LS. Nonencapsulated Streptococcus pneumoniae: emergence and pathogenesis. mBio. (2016) 22 7(2):e01792. 10.1128/mBio.01792-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01792-15</ArticleId><ArticleId IdType="pmc">PMC4807366</ArticleId><ArticleId IdType="pubmed">27006456</ArticleId></ArticleIdList></Reference><Reference><Citation>Langereis JD, de Jonge MI. Non-encapsulated streptococcus pneumoniae, vaccination as a measure to interfere with horizontal gene transfer. Virulence. (2017) 8(6):637–9. 10.1080/21505594.2017.1309492</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1309492</ArticleId><ArticleId IdType="pmc">PMC5626341</ArticleId><ArticleId IdType="pubmed">28328284</ArticleId></ArticleIdList></Reference><Reference><Citation>Danino D, Ben-Shimol S, van der Beek BA, Givon-Lavi N, Avni YS, Greenberg D, et al. Decline in pneumococcal disease in young children during the coronavirus disease 2019 (COVID-19) pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study. Clin Infect Dis Off Pub Infect Dis Soc Am. (2022) 75(1):e1154–64. 10.1093/cid/ciab1014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab1014</ArticleId><ArticleId IdType="pmc">PMC8754767</ArticleId><ArticleId IdType="pubmed">34904635</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Wang M, Huang X, Xie M, Pan L, Liu H, et al. Changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19. Front Public Health. (2021) 9:728768. 10.3389/fpubh.2021.728768</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.728768</ArticleId><ArticleId IdType="pmc">PMC8553983</ArticleId><ArticleId IdType="pubmed">34722440</ArticleId></ArticleIdList></Reference><Reference><Citation>Adegbola RA, DeAntonio R, Hill PC, Roca A, Usuf E, Hoet B, et al. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One. (2014) 9(8):e103293. 10.1371/journal.pone.0103293</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103293</ArticleId><ArticleId IdType="pmc">PMC4118866</ArticleId><ArticleId IdType="pubmed">25084351</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger R, von Kries R, van der Linden M, Rieck T, Siedler A, Falkenhorst G. Invasive pneumococcal disease in children under 16 years of age: incomplete rebound in incidence after the maximum effect of PCV13 in 2012/13 in Germany. Vaccine. (2018) 36(4):572–7. 10.1016/j.vaccine.2017.11.085</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.11.085</ArticleId><ArticleId IdType="pubmed">29258705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijayasri S, Hillier K, Lim GH, Harris TM, Wilson SE, Deeks SL. The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007–2017. PLoS One. (2019) 14(12):e0226353. 10.1371/journal.pone.0226353</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0226353</ArticleId><ArticleId IdType="pmc">PMC6910703</ArticleId><ArticleId IdType="pubmed">31834926</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D, et al. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in the Gambia: a population-based surveillance study. Lancet Infect Dis. (2016) 16(6):703–11. 10.1016/s1473-3099(16)00054-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(16)00054-2</ArticleId><ArticleId IdType="pmc">PMC4909992</ArticleId><ArticleId IdType="pubmed">26897105</ArticleId></ArticleIdList></Reference><Reference><Citation>Regev-Yochay G, Reisenberg K, Katzir M, Wiener-Well Y, Rahav G, Strahilevitz J, et al. Pneumococcal meningitis in adults after introduction of PCV7 and PCV13, Israel, July 2009–June 2015. Emerg Infect Dis. (2018) 24(7):1275–84. 10.3201/eid2407.170721</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2407.170721</ArticleId><ArticleId IdType="pmc">PMC6038733</ArticleId><ArticleId IdType="pubmed">29912694</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Wang Q, Yao K, Dong F, Song W, Liu G, et al. Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China. Eur J Clin Microbiol Infect Dis. (2021) 40(9):1833–42. 10.1007/s10096-021-04238-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-021-04238-x</ArticleId><ArticleId IdType="pubmed">33786728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zeng J, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis. (2017) 17(1):804. 10.1186/s12879-017-2880-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2880-0</ArticleId><ArticleId IdType="pmc">PMC5747162</ArticleId><ArticleId IdType="pubmed">29284419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian network for surveillance of resistant pathogens (ANSORP) study. Antimicrob Agents Chemother. (2012) 56(3):1418–26. 10.1128/aac.05658-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.05658-11</ArticleId><ArticleId IdType="pmc">PMC3294909</ArticleId><ArticleId IdType="pubmed">22232285</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Lahham A. Multicenter study of pneumococcal carriage in children 2 to 4 years of age in the winter seasons of 2017–2019 in Irbid and Madaba governorates of Jordan. PLoS One. (2020) 15(8):e0237247. 10.1371/journal.pone.0237247</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237247</ArticleId><ArticleId IdType="pmc">PMC7425857</ArticleId><ArticleId IdType="pubmed">32790696</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil S, Chen H, Lopes BS, Liu S, Wen F. Multidrug-resistant Streptococcus pneumoniae in young children. Lancet Microbe. (2023) 4(2):e69. 10.1016/s2666-5247(22)00323-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-5247(22)00323-8</ArticleId><ArticleId IdType="pubmed">36328027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>